Comprehensive tobacco cessation program for cancer patients, survivors, and caregivers
Building a Comprehensive Tobacco Cessation Program for Cancer Patients and Survivors: "A Breath of Fresh Air"
This program will try offering gold-standard medications (nicotine replacement, bupropion, or varenicline) plus behavioral counseling to help cancer patients, survivors, and caregivers quit tobacco.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 75 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Virginia Commonwealth University Academic / other |
| Locations | 1 site (Richmond, Virginia) |
| Trial ID | NCT05805722 on ClinicalTrials.gov |
What this trial studies
The program integrates evidence-based pharmacotherapy (nicotine replacement therapy, bupropion, or varenicline) with behavioral counseling into routine oncology care to test how well it can be delivered. Investigators will offer the gold-standard treatment to VCUHealth patients with a current or recent history of tobacco use and measure feasibility and acceptability of the procedures. The study focuses on practical implementation within a cancer center population that may face social determinants of health barriers to cessation. Results are intended to guide future efforts to make tobacco treatment a standard, accessible part of cancer care.
Who should consider this trial
Good fit: Ideal candidates are English-speaking VCUHealth patients with a documented cancer diagnosis (active or in remission) who currently use tobacco or have recently quit and can provide informed consent and attend program visits.
Not a fit: Patients who are not VCUHealth patients, who do not speak English, or who are unwilling or unable to use medications or participate in counseling are unlikely to benefit from this program.
Why it matters
Potential benefit: If successful, this program could increase quit rates and improve cancer outcomes and quality of life by making evidence-based tobacco treatment readily available in oncology care.
How similar studies have performed: Prior trials have shown that combining pharmacotherapy with counseling improves cessation rates, though fewer studies have tested comprehensive implementation specifically within cancer care settings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Provision of signed and dated informed consent form * Stated willingness to comply with study procedures and availability for the duration of the study * Have a documented history of cancer of any type, whether active or in remission * Identify as a current or recently-quit tobacco user Exclusion Criteria: * Not a VCUHealth patient * Non English-speaking
Where this trial is running
Richmond, Virginia
- Virginia Commonwealth University — Richmond, Virginia, United States (Recruiting)
Study contacts
- Principal investigator: Livingstone Aduse-Poku, PhD — Virginia Commonwealth University
- Study coordinator: Antonice Wall
- Email: walla2@vcu.edu
- Phone: 804-827-2357
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.